EGFR and KRAS mutation coexistence in lung adenocarcinomas

Autor: Sousa, Vitor Manuel Leitão De, Silva, Maria Reis, Alarcão, Ana Maria, D’Aguiar, Maria João, Ferreira, Teresa, Carvalho, Lina

Publikováno v: Diagnostic Pathology, Vol 1, Iss 1 (2015)

Lung cancer is one of the most common causes of cancer deaths. The development of EGFR targeted therapies, including monoclonal antibodies and tyrosine kinase inhibitors have generated an interest in the molecular characterization of these tumours. K

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15075a5cb0c70a80cf23c493214cec49
http://www.diagnosticpathology.eu/content/index.php/dpath/article/view/13

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

WITHDRAWN: Bronchial-pulmonary adenocarcinoma subtyping relates with different molecular pathways.

Autor: Sousa V; IAP-FMUC-Institute of Pathology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal; Pathology Institute, Coimbra University Hospital (HUC-CHUC), Coimbra, Portugal. Electronic address: vitorsousa77@netcabo.pt., Bastos B; IAP-FMUC-Institute of Pathology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal., Silva M; IAP-FMUC-Institute of Pathology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal., Alarcão AM; IAP-FMUC-Institute of Pathology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal., Carvalho L; IAP-FMUC-Institute of Pathology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal; Pathology Institute, Coimbra University Hospital (HUC-CHUC), Coimbra, Portugal.

Publikováno v: Revista portuguesa de pneumologia [Rev Port Pneumol] 2014 Aug 15. Date of Electronic Publication: 2014 Aug 15.